If you would like to inquire about all open trials, please contact 919.684.3401.
1 trial identified.
AHEP0731 Treatment of Children with All Stages of Hepatoblastoma with Temsirolimus (IND#122782, NCS#683864) Added to High Risk Stratum Treatment Phase: Phase III Sponsor: Cooperative Group Initiated Principal Investigator: Susan Kreissman Contact: Dr. Susan Kreissman Phone: 919.684.3401 Reference Number: 00021079 View this trial at ClinicalTrials.gov
Ways To Give
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.